Yu‐Jen Fang

1.6k total citations · 1 hit paper
27 papers, 568 citations indexed

About

Yu‐Jen Fang is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Yu‐Jen Fang has authored 27 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Yu‐Jen Fang's work include Helicobacter pylori-related gastroenterology studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (9 papers). Yu‐Jen Fang is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis C virus research (9 papers). Yu‐Jen Fang collaborates with scholars based in Taiwan, United States and Australia. Yu‐Jen Fang's co-authors include Chieh‐Chang Chen, Ming‐Shiang Wu, Jyh‐Ming Liou, Mei‐Jyh Chen, Jaw‐Town Lin, Ji‐Yuh Lee, Tsung‐Hua Yang, Chi‐Yang Chang, Jia‐Horng Kao and Jiing‐Chyuan Luo and has published in prestigious journals such as PLoS ONE, Gut and Scientific Reports.

In The Last Decade

Yu‐Jen Fang

26 papers receiving 561 citations

Hit Papers

Primary antibiotic resistance of Helicobacter pylori in t... 2023 2026 2024 2025 2023 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Jen Fang Taiwan 14 325 170 163 149 128 27 568
Chih‐Ming Liang Taiwan 17 539 1.7× 120 0.7× 246 1.5× 81 0.5× 206 1.6× 65 771
Suhaib Abudayyeh United States 12 332 1.0× 82 0.5× 146 0.9× 58 0.4× 123 1.0× 20 561
Mohamed Emara Egypt 11 201 0.6× 129 0.8× 58 0.4× 136 0.9× 84 0.7× 66 459
Ji‐Yuh Lee Taiwan 7 198 0.6× 59 0.3× 108 0.7× 53 0.4× 127 1.0× 14 356
Ali Akbar Shayesteh Iran 12 113 0.3× 128 0.8× 50 0.3× 84 0.6× 27 0.2× 52 393
Pravin Rathi India 12 294 0.9× 175 1.0× 109 0.7× 92 0.6× 64 0.5× 73 518
Annalisa de Leone Italy 11 155 0.5× 130 0.8× 74 0.5× 75 0.5× 90 0.7× 29 375
H Schwacha Germany 12 304 0.9× 324 1.9× 117 0.7× 268 1.8× 101 0.8× 24 689
Binnur Pınarbaşı Türkiye 16 144 0.4× 263 1.5× 72 0.4× 243 1.6× 33 0.3× 47 550
Sadhna Lal India 11 137 0.4× 82 0.5× 63 0.4× 40 0.3× 32 0.3× 54 679

Countries citing papers authored by Yu‐Jen Fang

Since Specialization
Citations

This map shows the geographic impact of Yu‐Jen Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Jen Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Jen Fang more than expected).

Fields of papers citing papers by Yu‐Jen Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Jen Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Jen Fang. The network helps show where Yu‐Jen Fang may publish in the future.

Co-authorship network of co-authors of Yu‐Jen Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Jen Fang. A scholar is included among the top collaborators of Yu‐Jen Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Jen Fang. Yu‐Jen Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chen‐Hua, Pin‐Nan Cheng, Yu‐Jen Fang, et al.. (2024). Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection. Journal of Hepatology. 82(4). 582–593. 13 indexed citations
2.
Liu, Chen‐Hua, Yu‐Ping Chang, Yu‐Jen Fang, et al.. (2024). Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals. Journal of Gastroenterology. 59(7). 609–620. 7 indexed citations
3.
Liu, Chen‐Hua, Yu‐Jen Fang, Tung‐Hung Su, et al.. (2023). Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of Clinical Medicine. 12(5). 2020–2020. 1 indexed citations
4.
Wu, Jia‐Ling, Cheng‐Hao Tseng, Yiling Wu, et al.. (2023). Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation. Clinical and Molecular Hepatology. 30(1). 98–108. 8 indexed citations
5.
Hong, Tzu‐Chan, Emad El‐Omar, Yu‐Ting Kuo, et al.. (2023). Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis. ˜The œLancet. Gastroenterology & hepatology. 9(1). 56–67. 63 indexed citations breakdown →
6.
Chung, Chen‐Shuan, Chieh‐Chang Chen, Kuan‐Chih Chen, et al.. (2022). Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patients. Scientific Reports. 12(1). 5798–5798. 3 indexed citations
7.
Fang, Yu‐Jen, Arvind Mukundan, Yu-Ming Tsao, Chien‐Wei Huang, & Hsiang‐Chen Wang. (2022). Identification of Early Esophageal Cancer by Semantic Segmentation. Journal of Personalized Medicine. 12(8). 1204–1204. 40 indexed citations
9.
Fang, Yu‐Jen, Mei‐Jyh Chen, Chieh‐Chang Chen, et al.. (2020). Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan. Journal of the Formosan Medical Association. 119(11). 1626–1633. 13 indexed citations
10.
Yang, Tsung‐Hua, Yu‐Jen Fang, Shih‐Jer Hsu, et al.. (2020). Micro-elimination of Chronic Hepatitis C by Universal Screening plus Direct Acting Antivirals for Incarcerated Persons in Taiwan. Open Forum Infectious Diseases. 30 indexed citations
11.
Chen, Chieh‐Chang, Wei‐Kai Wu, Chih‐Min Chang, et al.. (2020). Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles. Journal of the Formosan Medical Association. 119(12). 1791–1798. 23 indexed citations
12.
Liu, Chen‐Hua, Cheng‐Yuan Peng, Yu‐Jen Fang, et al.. (2020). Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis. Scientific Reports. 10(1). 9180–9180. 8 indexed citations
13.
Hsu, Shih–Jer, Yu‐Jen Fang, Tsung‐Hua Yang, et al.. (2019). Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C. Journal of the Formosan Medical Association. 118(8). 1187–1192. 16 indexed citations
14.
Chen, Mei‐Jyh, Chien-Chuan Chen, Yen-Nien Chen, et al.. (2018). Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection. The American Journal of Gastroenterology. 113(10). 1444–1457. 31 indexed citations
15.
Chen, Mei‐Jyh, Ming‐Shiang Wu, Chien-Chuan Chen, et al.. (2017). Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials. Journal of Antimicrobial Chemotherapy. 72(12). 3481–3489. 23 indexed citations
16.
Liu, Chen‐Hua, Chun‐Jen Liu, Tung‐Hung Su, et al.. (2017). Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection. Open Forum Infectious Diseases. 4(1). ofx028–ofx028. 36 indexed citations
17.
Hsu, Yao‐Chun, Lein‐Ray Mo, Chi‐Yang Chang, et al.. (2016). Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients. Clinical Gastroenterology and Hepatology. 14(10). 1490–1498.e3. 34 indexed citations
18.
Liou, Jyh‐Ming, Chi‐Yang Chang, Mei‐Jyh Chen, et al.. (2015). The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study. PLoS ONE. 10(5). e0124199–e0124199. 68 indexed citations
19.
Fang, Yu‐Jen, Tsu‐Yao Cheng, Meng‐Shun Sun, et al.. (2012). Suggested cutoff tumor size for management of small EUS-suspected gastric gastrointestinal stromal tumors. Journal of the Formosan Medical Association. 111(2). 88–93. 29 indexed citations
20.
Fang, Yu‐Jen, Hsiu–Po Wang, Cheng‐Maw Ho, & Kao‐Lang Liu. (2008). Barium appendicitis. Surgery. 146(5). 957–958. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026